Pu Xuan
Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival
Xuan, Pu; Storr, Sarah J.; Zhang, Yimin; Rakha, Emad; Green, Andrew R.; Ellis, Ian O.; Martin, Stewart G.
Authors
Sarah J. Storr
Yimin Zhang
EMAD RAKHA Emad.Rakha@nottingham.ac.uk
Professor of Breast Cancer Pathology
Andrew R. Green
Ian O. Ellis
Stewart G. Martin
Abstract
Impaired apoptosis is one of the hallmarks of cancer. Caspase-3 and -8 are key regulators of the apoptotic response and have been shown to interact with the calpain family, a group of cysteine proteases, during tumorigenesis. The current study sought to investigate the prognostic potential of caspase-3 and -8 in breast cancer, as well as the prognostic value of combinatorial caspase and calpain expression. A large cohort (n = 1902) of early stage invasive breast cancer patients was used to explore the expression of caspase-3 and -8. Protein expression was examined using standard immunohistochemistry on tissue microarrays. High caspase-3 expression, but not caspase-8, is significantly associated with adverse breast cancer-specific survival (P = 0.008 and P = 0.056, respectively). Multivariate analysis showed that caspase-3 remained an independent factor when confounding factors were included (hazard ratio (HR) 1.347, 95% confidence interval (CI) 1.086–1.670; P = 0.007). The analyses in individual subgroups demonstrated the significance of caspase-3 expression in clinical outcomes in receptor positive (ER, PR or HER2) subgroups (P = 0.001) and in non-basal like subgroup (P = 0.029). Calpain expression had been previously assessed. Significant association was also found between high caspase-3/high calpain-1 and breast cancer-specific survival in the total patient cohort (P = 0.005) and basal-like subgroup (P = 0.034), as indicated by Kaplan–Meier analysis. Caspase-3 expression is associated with adverse breast cancer-specific survival in breast cancer patients, and provides additional prognostic values in distinct phenotypes. Combinatorial caspase and calpain expression can predict worse prognosis, especially in basal-like phenotypes. The findings warrant further validation studies in independent multi-centre patient cohorts.
Citation
Xuan, P., Storr, S. J., Zhang, Y., Rakha, E., Green, A. R., Ellis, I. O., & Martin, S. G. (in press). Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival. Apoptosis, https://doi.org/10.1007/s10495-016-1323-5
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 25, 2016 |
Online Publication Date | Oct 31, 2016 |
Deposit Date | Jan 12, 2017 |
Publicly Available Date | Jan 12, 2017 |
Journal | Apoptosis |
Print ISSN | 1360-8185 |
Electronic ISSN | 1573-675X |
Publisher | Springer Verlag |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1007/s10495-016-1323-5 |
Keywords | Breast cancer, Caspase, Calpain, Breast cancer-specific survival, Biomarker |
Public URL | https://nottingham-repository.worktribe.com/output/820939 |
Publisher URL | http://link.springer.com/article/10.1007%2Fs10495-016-1323-5 |
Contract Date | Jan 12, 2017 |
Files
art%3A10.1007%2Fs10495-016-1323-5.pdf
(1.6 Mb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by/4.0
You might also like
Simply-supported multi-layered beams for energy harvesting
(2016)
Journal Article
Cell Division Cycle 6 (CDC6) is an Independent Prognostic Biomarker in Breast Cancer
(2024)
Journal Article
The role of the ALKBH5 RNA demethylase in invasive breast cancer
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search